Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 7
Treatment-assignment count: 0
Stratification count: 0
Cdx Established Context
MSI-H / dMMR
gastric cancer · Small Molecule Inhibitor
MSI-H / dMMR is flagged as cdx established context because public trials show inclusion required evidence in 10 contexts. FDA CDx context exists.
Threshold snippets
Fragmentation view
Threshold count: 23
Common snippets: dMMR | dMMR | dMMR
Threshold label: Moderate
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: Medium
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT06152523 | https://clinicaltrials.gov/study/NCT07511894 | https://clinicaltrials.gov/study/NCT05994456 | https://clinicaltrials.gov/study/NCT07262619 | https://clinicaltrials.gov/study/NCT07259473 | https://clinicaltrials.gov/study/NCT05933980 | https://clinicaltrials.gov/study/NCT06346197 | https://clinicaltrials.gov/study/NCT06580574 | https://clinicaltrials.gov/study/NCT05832892 | https://clinicaltrials.gov/study/NCT04795661